Paeds Vivas · genetics-dysmorphology-and-metabolism
Glycogen-storage and carbohydrate metabolism disorders — branching viva
Branching viva on the glycogen-storage and carbohydrate metabolism disorders: recognising the hepatic glycogenoses through hepatomegaly with fasting hypoglycaemia and lactic acidosis, separating Pompe disease by its cardiomyopathy and hypotonia, delivering the 'prevent fasting' management with cornstarch and continuous glucose, and holding galactosaemia and hereditary fructose intolerance as the toxic-sugar disorders.
On this page & tools
Target exams
Opening framework
My framework has three layers. First, the recognition — a child with hepatomegaly and fasting hypoglycaemia with lactic acidosis is a hepatic glycogen storage disease until proven otherwise, and the metabolic fingerprint decides which one. Second, the mechanism — the block's position along glycogenolysis determines whether the child starves the blood of glucose (the hepatic GSDs) or swells a lysosome (Pompe) or starves exercising muscle (McArdle). Third, the management — the unifying move is to prevent fasting and catabolism, with Pompe as the enzyme-replacement exception. [1]
You have read the opening of this viva. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship atlas.
References5Show ledgerHide ledger
- [1]Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GPA. Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr, 2002.PMID 12373584
- [5]Kishnani PS, Steiner RD, Bali D, et al. Pompe disease diagnosis and management guideline. Genet Med, 2006.PMID 16702877
- [6]Schoser B, Roberts M, Byrne BJ, et al. Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL). Lancet Neurol, 2021.PMID 34800400
- [12]Van Calcar SC, Bernstein LE, Rohr FJ, et al. A re-evaluation of life-long severe galactose restriction for the nutrition management of classic galactosemia. Mol Genet Metab, 2014.PMID 24857409
- [15]Boers SJ, Visser G, Smit PG, Fuchs SA. Liver transplantation in glycogen storage disease type I. Orphanet J Rare Dis, 2014.PMID 24716823